2021
DOI: 10.1177/20552076211067651
|View full text |Cite
|
Sign up to set email alerts
|

Use of home pulse oximetry with daily short message service messages for monitoring outpatients with COVID-19: The patient's experience

Abstract: Studies have shown COVID-19 patients may have a low oxygen saturation (SpO2) independent of visible respiratory distress, a phenomenon termed “silent hypoxia.” Silent hypoxia creates uncertainty in the outpatient setting for clinicians and patients alike. In this study, we examined the potential for pulse oximeters in identifying early signs of clinical deterioration. We report descriptive results on COVID-positive patients’ experiences with a comprehensive home monitoring tool comprised of home SpO2 measureme… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…This high level of patient acceptance has been previously reported by other studies who have described excellent patient satisfaction with virtual care during the COVID-19 pandemic. 2,[19][20][21][22][23] Aside from the near ubiquitous symptom of cough, dyspnoea was the symptom most frequently identified within the hypoxic group and thus patients reporting dyspnoea as a prominent symptom of their COVID-19 symptom profile should have access to home pulse oximetry. Conversely, cough in the absence of other respiratory symptoms was not a useful predictor of clinical deterioration, hypoxia and escalation to an ED.…”
Section: Discussionmentioning
confidence: 99%
“…This high level of patient acceptance has been previously reported by other studies who have described excellent patient satisfaction with virtual care during the COVID-19 pandemic. 2,[19][20][21][22][23] Aside from the near ubiquitous symptom of cough, dyspnoea was the symptom most frequently identified within the hypoxic group and thus patients reporting dyspnoea as a prominent symptom of their COVID-19 symptom profile should have access to home pulse oximetry. Conversely, cough in the absence of other respiratory symptoms was not a useful predictor of clinical deterioration, hypoxia and escalation to an ED.…”
Section: Discussionmentioning
confidence: 99%
“…A study from the Netherlands, however, could not confirm a lower rate of nurse entries when continuous monitoring was made available to patients admitted to hospital with suspicion of COVID-19. 30 To relieve pressure on hospital beds, several initiatives tried to reduce the length of stay for patients with COVID-19 requiring hospital admission, either by allowing more comprehensive home monitoring and treatment in an effort to avoid or delay hospitalisation, 31 or by offering recovering patients earlier discharge from hospital with home monitoring of vital signs, home administration of low-flow supplemental oxygen (if needed) and daily telecontact with the care team. A small randomised trial by van Goor et al 32 confirmed that remote hospital care for recovering patients with COVID-19 is feasible, but the authors were unable to demonstrate an increase in hospital-free days in the 30 days following randomisation.…”
Section: Remote Patient Monitoring: Lessons Learnt During the Covid-1...mentioning
confidence: 99%
“…Community-based telemonitoring of symptoms scores, temperature, oximetry, and blood pressure supported by self-management information and/or remote monitoring proved to be a cost-effective alternative to hospitalisation. [15,16,18,[154][155][156][157][158] Although a rapid systematic review was unable to confirm safety due to lack of standardised reporting, [18] mixed-method evaluation of individual programmes concluded that they were reassuring to patients (especially the oximetry), [15,155,158] acceptable to clinicians, [15,154,158] able to detect signs of deterioration, [15,158,159] and a safe approach for selected high-risk patients with mild-to-moderate COVID-19. [15,16,18,[157][158][159] Economic analysis was limited to reporting resources used and the amount spent per patient monitored.…”
Section: Digital Innovation To Manage Covid-19 Infectionsmentioning
confidence: 99%